With regard to a benchmark, we certainly monitor the epidemiology whether it's in Canada or elsewhere. We are looking at importation risk, at the results of our testing regime, at the positivity rates, for example, in the border testing to determine whether readjustments will be made to the measures. We're certainly looking, at the domestic level, at vaccinations and at the impact on the health care system in Canada. Those are some of the elements that go into the modelling that is done to determine whether we have to make adjustments.
On February 28th, 2022. See this statement in context.